Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$1.59−0.19 (-10.67%)
Close on Nov 18, 2026Market cap $52.03MP/E –Yield –
Insight Molecular Diagnostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Insight Molecular Diagnostics's revenue for the twelve months ending Jun 30, 2026 was $1.67M, down 60.8% year over year. For fiscal 2025 it was $4.06M, up 115.6% from the year before. The highest annual figure on record is $4.06M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.06M | +115.6% |
| FY2024 | Dec 31, 2024 | $1.88M | +25.1% |
| FY2023 | Dec 31, 2023 | $1.50M | +56.9% |
| FY2022 | Dec 31, 2022 | $958.00K | -56.4% |
| FY2021 | Dec 31, 2021 | $2.20M | +80.8% |
| FY2020 | Dec 31, 2020 | $1.22M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $239.00K | -53.9% |
| Q1 FY2026 | Mar 31, 2026 | $32.00K | -98.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.14M | -23.4% |
| Q3 FY2025 | Sep 30, 2025 | $260.00K | +126.1% |
| Q2 FY2025 | Jun 30, 2025 | $518.00K | +398.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.14M | +1114.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.49M | +373.2% |
| Q3 FY2024 | Sep 30, 2024 | $115.00K | -73.2% |
| Q2 FY2024 | Jun 30, 2024 | $104.00K | -77.5% |
| Q1 FY2024 | Mar 31, 2024 | $176.00K | -40.7% |
| Q4 FY2023 | Dec 31, 2023 | $314.00K | +14.6% |
| Q3 FY2023 | Sep 30, 2023 | $429.00K | +540.3% |
| Q2 FY2023 | Jun 30, 2023 | $463.00K | +95.4% |
| Q1 FY2023 | Mar 31, 2023 | $297.00K | -21.8% |
| Q4 FY2022 | Dec 31, 2022 | $274.00K | -92.4% |
| Q3 FY2022 | Sep 30, 2022 | $67.00K | -93.2% |
| Q2 FY2022 | Jun 30, 2022 | $237.00K | -88.3% |
| Q1 FY2022 | Mar 31, 2022 | $380.00K | -66.2% |
| Q4 FY2021 | Dec 31, 2021 | $3.59M | +613.5% |
| Q3 FY2021 | Sep 30, 2021 | $984.00K | +77.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.03M | +1319.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.12M | +6925.0% |
| Q4 FY2020 | Dec 31, 2020 | $503.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $555.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $143.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $16.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?